Showing results (51-60 of 209) with videos related to
Sort By:
Pageof 21
Nature Immunology|July 18, 2024
T cell dysfunction and therapeutic intervention in cancerCaitlin C Zebley, Dietmar Zehn, Stephen Gottschalk, et al.Journal of Experimental & Clinical Cancer Research : CR|April 2, 2024
A high-content screen of FDA approved drugs to enhance CAR T cell function: ingenol-3-angelate improves B7-H3-CAR T cell activity by upregulating B7-H3 on the target cell surface via PKCα activationHa Won Lee, Carla O'Reilly, Alex N Beckett, et al.Cytotherapy|June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumorsDevin Murphy, Yu Bi, Aysha Patel, et al.Cancers|September 10, 2021
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor ModelsMarianna Csaplár, János Szöllősi, Stephen Gottschalk, et al.Methods in Molecular Biology (Clifton, N.J.)|November 23, 2016
EBV-Directed T Cell Therapeutics for EBV-Associated LymphomasLauren P McLaughlin, Stephen Gottschalk, Cliona M Rooney, et al.Cancers|December 23, 2023
Cytokine Modification of Adoptive Chimeric Antigen Receptor Immunotherapy for GlioblastomaKristen D Pawlowski, Joseph T Duffy, Stephen Gottschalk, et al.Molecular Therapy. Methods & Clinical Development|March 20, 2018
Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of GliomaZhongzhen Yi, Brooke L Prinzing, Felicia Cao, et al.Oncoimmunology|December 3, 2021
Unifying heterogeneous expression data to predict targets for CAR-T cell therapyPatrick Schreiner, Mireya Paulina Velasquez, Stephen Gottschalk, et al.The Lancet. Oncology|October 2, 2013
Is cancer gene therapy an empty suit?Malcolm K Brenner, Stephen Gottschalk, Ann M Leen, et al.Plos One|December 19, 2013
A vaccine that co-targets tumor cells and cancer associated fibroblasts results in enhanced antitumor activity by inducing antigen spreadingStephen Gottschalk, Feng Yu, Minjun Ji, et al.Pageof 21